AzTrials
AzTrials

Spinal Cord Injuries (SCI)NCT07901985

A Rehabilitation Data Collection Study in Patients With Spinal Cord Injury

An observational study of Spinal Cord Injuries (SCI), run by Seoul National University Hospital at 1 site in South Korea.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to build a rehabilitation registry for people with spinal cord injury (SCI) in Korea and to create foundational data for predicting patients' long-term function. Read more about this study

Who is it for?
Any age
Conditions the study is for
Spinal Cord Injuries (SCI)
How many people
250 participants
Where
1 siteSouth Korea
Study dates
7 Jul 2024to 31 Dec 2026
How long will I take part?
12 Months
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: patients with spinal cord injury (SCI), Demographic, injury-related, healthcare utilization, health and functional, and clinical information are collected from patients with spinal cord injury admitted to the National Traffic Injury Rehabilitation Hospital.

Who may be able to join

  • [Phase 1(baseline)]
  • Patients admitted with spinal cord injury to the Department of Rehabilitation Medicine at the National Traffic Injury Rehabilitation Hospital
  • Patients able to understand and respond to the study questionnaire without difficulty
  • [Phases 2 and 3 (follow-up)]
  • Patients who participated in the survey during Phase 1 (i.e., those who had been admitted with spinal cord injury to the Department of Rehabilitation Medicine at the National Traffic Injury Rehabilitation Hospital)
  • Patients who provided consent at the time of the Phase 1 survey and indicated their willingness to take part in the follow-up surveys at approximately 6 months post-discharge (Phase 2) and approximately 12 months post-discharge (Phase 3)

Who cannot join

  • Patients with a disability that makes participation difficult during administration of the survey
  • Participants otherwise judged by the investigator to be unsuitable for the study
  • Patients who participated in the Phase 1 survey but did not consent to the follow-up surveys in Phases 2 and 3

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

South Korea1 site, 1 recruiting
  • National Traffic Injury Rehabilitation Hospital

    Yangpyeong, Gyeonggi-do, 12564

    Ja Ho Leigh, Clinical Associate Professor, 82-10-2871-9245, mazican@gmail.com

    Yun Hwa Jung, Research Professor, 82-10-7379-9353, pagroupstudy@naver.com

    Recruiting

Other trials in South Korea

About this study

Official title: A Data Collection Study for Developing a Prognostic Model in Patients With Central Nervous System Disorders: A Rehabilitation Study in Individuals With Spinal Cord Injury

The goal of this observational study is to build a rehabilitation registry for people with spinal cord injury (SCI) in Korea and to create foundational data for predicting patients' long-term function. The main question it aims to answer is:

  • Can a person's long-term level of disability and functional status after SCI be predicted by collecting medical and socioeconomic information together?
Read more

Participants receiving inpatient rehabilitation after a spinal cord injury will:

  • Complete a first (baseline) survey and standard assessments of daily functioning, walking ability, quality of life, and disability at the time of admission
  • Complete the same assessments again about 6 months and 12 months after discharge
  • Provide information on their health, use of medical services, employment, income, and social participation during follow-up
Read the detailed description

This is a prospective, single-center observational registry study conducted at the National Traffic Injury Rehabilitation Hospital in Korea. It forms the first stage of a multi-year initiative (2024-2026, funded by the National Rehabilitation Center) intended to design and establish a comprehensive rehabilitation registry for patients with spinal cord injury (SCI) and to generate foundational data for predicting patients' long-term functional status.

Eligible patients are enrolled during inpatient rehabilitation using a systematic selection approach, after the purpose and procedures of the study-including the follow-up surveys-are explained and written informed consent is obtained. Recruitment continues from study initiation in 2024 until the target enrollment is reached or the study ends in 2026. Data are collected in three waves: a baseline survey at the time of admission, administered by an internal researcher by telephone or in person; and two follow-up surveys, conducted at approximately 6 and 12 months after discharge through interviews performed by a professional research organization. Across these waves, the registry captures demographic and injury-related characteristics, use of health services, health and functional status, and clinical information; the follow-up waves additionally capture post-discharge health, healthcare utilization, employment, household income, and social participation. Data are drawn from a combination of patient-reported responses, physician-collected information, and abstraction from medical records. (Eligibility criteria and specific outcome measures are provided in the corresponding sections and are not repeated here.)

Registry procedures and quality factors:

  • Documentation and data dictionary: The full data-collection process is documented in advance, including the protocol, operations and management policies, procedures, data-collection instruments, a complete list of data elements with their definitions, the screening process, the method for generating unique patient registration numbers to prevent duplicate enrollment, and training for data collectors.
  • Roles and responsibilities: Personnel involved in data collection and their specific responsibilities are defined, with clear role assignment.
  • Data validation and quality assurance: Completed questionnaires are reviewed immediately for missing responses or errors, with re-confirmation from the participant when needed, and data are captured using double data entry to ensure accuracy.
  • Data checks: A data management manual is used to review missing values, incorrectly entered values, out-of-range values, and logically impossible values.
  • Source data: Each data element is characterized by whether it derives from a primary or secondary source and whether it is patient-reported, physician-collected, or extracted from medical records.
  • Data storage and security: Identifiable information (e.g., name, resident registration number, patient number) is anonymized and replaced with randomly generated codes, and only coded files are used for analysis. Original data are stored with two-level encryption (file- and sheet-level) on encrypted media kept on a password-protected computer in a locked room, with documented deletion/modification history, a backup plan, and a security plan.
  • Sample size: The planned sample size is 250 participants. A power analysis (G*Power; medium effect size 0.60, two-sided α = 5%, power ≥ 95%) established a required minimum of approximately 100 evaluable participants; enrollment is set at 250 to account for an estimated 20% attrition and to preserve data quality by offsetting loss from missing data.
  • Missing data: Missing, out-of-range, and inconsistent values are addressed through the data management manual, and the planned enrollment of 250 participants helps limit reductions in the analyzable sample due to attrition and missing data.
  • Statistical analysis: Collected data are summarized using descriptive statistics. Comparative analyses (t-tests, analysis of variance, and chi-square tests) examine differences by characteristics such as sex, age group, and injury type-for example, in rehabilitation service utilization and timing of home return at baseline, and in post-discharge healthcare utilization and health outcomes at follow-up.
Keywords
Spinal cord injury, Rehabilitation, Registry
Medical subject headings
Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07901985
Study groupRoleWhat they receive
Patients with spinal cord injuryDemographic, injury-related, healthcare utilization, health and functional, and clinical information are collected from patients with spinal cord injury admitted to the National Traffic Injury Rehabilitation Hospital.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Level of disability (WHODAS 2.0 total score)

    Level of disability is measured using the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0). The summary score ranges from 0 to 100, with higher scores indicating greater disability (a worse outcome).

    Measured: Phase1. Baseline survey (at admission) / Phase2. Follow-up survey 1 (approximately 6 months post-discharge) / Phase3. Follow-up survey 2 (approximately 12 months post-discharge)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Oct 2026
  2. Study start7 Jul 2024
  3. Primary completion30 Nov 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
250 participants (estimated)
Target duration
12 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT07901985
Sponsor's protocol ID
2024-03-002
Status last verified
Aug 2026
First submitted
8 Oct 2026
Last updated
28 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Spinal Cord Injuries (SCI), run by Seoul National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Level of disability (WHODAS 2.0 total score) (time frame: Phase1. Baseline survey (at admission) / Phase2. Follow-up survey 1 (approximately 6 months post-discharge) / Phase3. Follow-up survey 2 (approximately 12 months post-discharge)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in